EcoDrugPlus

Integrin Subunit Beta 3

Ensembl ID : ENSLACG00000009401
Gene Symbol: ITGB3
2 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSLACG00000015336
Gene Symbol: ITGB5
2 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSLACG00000000408
Gene Symbol: ITGB6
4 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSLACG00000016456
Gene Symbol: ITGB7
4 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSLACG00000001236
Gene Symbol: ITGB8
4 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSLACG00000016246
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Interleukin 6 (Interferon, Beta 2)

Ensembl ID : ENSLACG00000008220
Gene Symbol: IL6
3 Cross references
162 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSLACG00000004687
Gene Symbol: LOC102363090
3 Cross references
183 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSLACG00000014588
Gene Symbol: IDH1
4 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSLACG00000017975
Gene Symbol: IDH2
4 Cross references
262 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSLACG00000007874
Gene Symbol: KEAP1
4 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSLACG00000009789
Gene Symbol: KDR
4 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).